Contribution of the APOE Genotype to Cognitive Impairment in Individuals With NOTCH3 Cysteine-Altering Variants.
Yu-Wen Cheng, Yi-Chu Liao, Chih-Hao Chen...
https://pubmed.ncbi.nlm.nih.gov/37982214/Actively Recruiting
Led by National Taiwan University Hospital · Updated on 2026-01-20
500
Participants Needed
1
Research Sites
104 weeks
Total Duration
Researchers are studying patients with cerebral small vessel disease CSVD, a condition diagnosed through clinical signs and brain imaging. This study aims to understand the differences between genetic and non-genetic forms of CSVD by analyzing specific genes linked to the disease. Patients will be grouped based on their genetic test results and followed over time to observe their health outcomes. All participants will undergo next-generation sequencing NGS targeting five genes associated with CSVD NOTCH3, HTRA1, GLA, TREX1, and COL4A1. Based on the results, patients will be classified into genetic or non-genetic groups. Brain MRI scans will be performed at the start of the study and repeated at least once during the one- or two-year follow-up period, depending on availability. Participants will be monitored for at least two years to track clinical features and outcomes such as stroke and dementia. The main measure is the number of patients who experience a new stroke within two years. Secondary measures include the number of patients who develop dementia. The study involves regular evaluations including brain imaging and clinical assessments to better understand CSVDs progression and impact.
CONDITIONS
Taiwan Associated Genetic and Nongenetic Small Vessel Disease
S
Sung-Chun Tang, MD, PhD
C
Chih-Hao Chen, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Taiwan University Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - At baseline and at least once during 1 to 2 years of follow-up
Participants undergo MRI scans to assess cerebral small vessel disease.
1 baseline visit and at least 1 follow-up visit within 1 to 2 years
Duration - 2 years
Participants are monitored for clinical outcomes including stroke and dementia over 2 years.
Periodic assessments during 2 years
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Yu-Wen Cheng, Yi-Chu Liao, Chih-Hao Chen...
https://pubmed.ncbi.nlm.nih.gov/37982214/Marinus Fislage, Chih-Hao Chen, Yu-Wen Cheng...
https://pubmed.ncbi.nlm.nih.gov/39493517/Ying-Chi Shen, Ya-Fang Chen, Yu-Wen Cheng...
https://pubmed.ncbi.nlm.nih.gov/39392097/Chih-Hao Chen, Yung-Tsai Chu, Ya-Fang Chen...
https://pubmed.ncbi.nlm.nih.gov/35781912/Ruiting Zhang, Chih-Hao Chen, Sophie Tezenas Du Montcel...
https://pubmed.ncbi.nlm.nih.gov/37652700/Chao-Wen Lin, Zih-Wei Yang, Chih-Hao Chen...
https://pubmed.ncbi.nlm.nih.gov/35617208/National Taiwan University Hospital
Lead Sponsor